BIOMEDICAL INVESTMENTS
Biomedical Investments (BMI) is an Israeli-based private investment firm, which specializes in the healthcare field (medical devices and biotechnology). The company focuses its investments on start-ups with breakthrough technologies, applicable in emerging therapeutic segments. Among the company's investors are: Mr. Leonard Abramson, who is a shareholder and member of the board, Teva Pharmaceuticals, which develops, manufactures and markets generic and branded human pharmaceuticals, Arison Investments, which is an Israeli investment group and Professor Benad Goldwasser, who is shareholder and Managing director of the company.
BIOMEDICAL INVESTMENTS
Founded:
1997-01-01
Status:
Closed
Technology used in webpage:
012 Smile
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2006-09-27 | Gamida Cell | Biomedical Investments investment in Series D - Gamida Cell | 16 M USD |
| 2006-07-24 | TransPharma Medical | Biomedical Investments investment in Series C - TransPharma Medical | 18 M USD |
| 2004-08-09 | ColBar LifeScience Ltd. | Biomedical Investments investment in Series D - ColBar LifeScience Ltd. | 7.25 M USD |
| 2003-01-18 | TransPharma Medical | Biomedical Investments investment in Series B - TransPharma Medical | 8.9 M USD |
| 2001-05-15 | Remon Medical Technologies | Biomedical Investments investment in Series A - Remon Medical Technologies | 10 M USD |
| 2001-01-01 | TransPharma Medical | Biomedical Investments investment in Series A - TransPharma Medical | 6.5 M USD |
More informations about "Biomedical Investments"
Biomedical Investments – Investors Database - Unicorn Nest
This Biomedical Investments works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The typical case for the fund is to invest in …See details»
2025 Biomedical Pitch Competition Registration – Boston Capital ...
You are invited to the 2025 Biomedical Pitch Competition, connecting biomedical start-ups with investors and other business accelerator resources. ... –Potential direct equity investment from …See details»
VC funding trends in biotechnology | McKinsey
Dec 12, 2023 Amid a challenging public-market environment, venture capital (VC) funding has provided a much-needed lifeline to fuel biotech innovation. Despite also registering a decline after peaking in 2021, with several …See details»
Industry Analysis Reports - BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... This report investigates …See details»
Life sciences - Invest in Canada
In Ontario and Québec, large life sciences centres like Toronto, Mississauga and Greater Montréal serve as research and innovation hubs, bringing together hospitals, business incubators, research organizations and post-secondary …See details»
Industry Data - BIOTECanada
Since 2019, the Canadian life sciences industry has witnessed substantial growth as a result of national and global investment within the sector, indicating confidence from investors in the …See details»
Healthcare & Biotechnology - Cooper Family Office
Ms. Sakopoulos is active in portfolio investments in healthcare, biotechnology, hedge funds, private equity, and venture. She co-leads the Women in Family Office Group that focuses on …See details»
Biomanufacturing: Projects underway - Canada
Government of Canada investments of more than $2.3B in 41 projects in the biomanufacturing, vaccine and therapeutics ecosystem, strengthening domestic pandemic response capabilities …See details»
Backgrounder – Government of Canada investments in the …
The Government of Canada’s number one priority is to protect the health of Canadians. Since the outset of the pandemic, the government has made a series of investments in …See details»
Biomedical Investments - Crunchbase Investor Profile & Investments
Biomedical Investments provides its investments to early-stage digital health startup companies. Lists Featuring This Company. ... 9,870 Number of Organizations • $188.7B Total Funding …See details»
Understanding Clinical Research Programs for Life Science Startups
Jan 14, 2025 The low-interest-rate environment and heightened public interest in healthcare led to increased investments in vaccine development and immunotherapies. This surge, however, …See details»
$140 Million Investment Positions B.C. as a Leader in Life Sciences
Sep 3, 2024 Canada’s $140 Million Investment Propels B.C. Towards Global Leadership in Life Sciences. The Government of Canada recently announced a landmark investment of $140 …See details»
Investments on grants for biomedical research by funder, type of …
Presented here is information on investments on biomedical grants for 2022 by 10 funders that reported these data to World RePORT. See more about the scope and limitations of World …See details»
Just how good an investment is the biopharmaceutical sector?
Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly …See details»
Financial intermediation and the funding of biomedical innovation: …
Apr 1, 2023 More generally, the real options literature can provide some insights into some of the observed patterns of biomedical R&D investment. First, as Myers (2015) lays out, R&D for …See details»
Biomedical Investments - Investments, Portfolio & Company Exits
Biomedical Investments 's most notable exits include Gamida Cell, ... Which industries has this organization had the most exits in? Show . Gamida Cell Gamida Cell is a biopharmaceutical …See details»
An Inside Look at Three Life Science Investment Hubs on the Rise
2 days ago Beyond Switzerland’s competitive tax rates and flexible labour markets, factors that continue to attract investment to Switzerland, the Basel area offers a solid life sciences …See details»
Orchestra BioMed (OBIO): Breakthrough Device Designation Gives ...
6 hours ago Summary. Orchestra BioMed Holdings' AVIM product received FDA breakthrough device designation, accelerating approval and offering speculative optimism for investors.See details»
Adamant Biomedical Investments AG - Crunchbase
Adamant Biomedical Investments is a Swiss asset manager with exclusive focus on healthcare. Their core competence is research. Their services include advisory and portfolio management …See details»
Novartis plans to expand its US-based manufacturing and R&D …
Apr 10, 2025 Expanded US manufacturing and R&D presence with investment in 10 facilities, ... expected to open between 2028 and 2029, will serve as the epicenter of the Novartis West …See details»